Julye C. Lavoie

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver

Julye C. Lavoie, Joseph M. Connors, Gordon L. Phillips et al. · Blood · 2005 · 124 citations · Full text

Medicine, Oncology, Cell Therapy +14

Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma*

Richard Doocey, Cynthia L. Toze, Joseph M. Connors et al. · British Journal of Haematology · 2005 · 87 citations · Full text

Medicine, Hematology, Oncology +15

Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels

Donna L. Forrest, Shannon Trainor, Ryan R. Brinkman et al. · Leukemia Research · 2008 · 81 citations

Life Sciences, Hematology, Oncology +11

Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease

Cynthia L. Toze, Alia Galal, Michael J. Barnett et al. · Bone Marrow Transplantation · 2005 · 79 citations

Life Sciences, Immunology, Oncology +17

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens

Yasser Abou-Mourad, Benny Lau, M. J. Barnett et al. · Bone Marrow Transplantation · 2009 · 75 citations

Medicine, Hematology, Immunotherapy +3